The emerging approach of the medication represents a major advance in the care of the condition. Different to existing therapies, tirzepatide targets dual pathways – the GLP-1 hormone and GIP – resulting in https://tirzepatide-peptide586489.dsiblogger.com/75139094/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment